Study of a BALB/c Mouse Model for Allergic Asthma

• Published in: Toxicological research (Seoul) 2008, 24(4), , pp.253-261
• Main Authors: Yang, Y.S. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), Yang, M.J. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), Cho, K.H. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), Lee, K.H. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), Kim, Y.B. (Korea Institute of Toxicology, Daejeon, Republic of Korea), Kim, J.S. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), Kang, M.G. (Korea Institute of Toxicology, Daejeon, Republic of Korea), Song, C.W. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Jeongeup, Republic of Korea), E-mail: [e-mail]
• Format: Article
• Language: English
• Subjects: ASMA; ASTHMA; ASTHME; Biomedicine; CITOQUINAS; CYTOKINE; CYTOKINES; GRANULOCITOS; GRANULOCYTE; GRANULOCYTES; Immunoglobulin E; MICE; Pharmacology/Toxicology; RATON; SOURIS; 예방의학
• ISSN: 1976-8257; 2234-2753
• DOI: 10.5487/TR.2008.24.4.253

Allergic asthma is a worldwide public health problem and a major socioeconomic burden disease. It is a chronic inflammatory disease marked by airway eosinophilia and goblet cell hyperplasia with mucus hypersecretion. Mouse models have proven as a valuable tool for studying human asthma. In the present report we describe a comparison of mouse asthma models. The experiments were designed as follows: Group Ⅰ was injected with ovalbumin (OVA, i.p.) on day 1 and challenged with 1% OVA (aerosol exposure) on days 14~21. Group Ⅱ was injected on day 1, 14 and aerosolimmunized on days 14~21. Group Ⅲ was injected on day 1, 14 and immunized by 1% OVA aerosol on days 18~21. We assessed asthma induction by determining the total number of white blood cells (WBC) and eosinophils as well as by measuring cytokine levels in bronchoalveolar lavage fluid (BALF). In addition, we evaluated the histopathological changes of the lungs and determined the concentration of immunoglobulin E (IgE) in serum. Total WBC, eosinophils, Th2 cytokines (IL-4, IL-13) and IgE were significantly increased in group Ⅰ relative to the other groups. Moreover, histopathological studies show that group Ⅰ mice show an increase in the infiltration of inflammatory cell-in peribronchial and perivascular areas as well as an overall increase in the number of mucus-containing goblet cells relative to other groups. These data suggest that group Ⅰ can be a useful model for the study of human asthma pathobiology and the evaluation of existing and novel therapeutic agents.